|
Apr 24
|
Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO
|
|
Apr 22
|
Regeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Therapy (ASGCT)
|
|
Apr 22
|
Agenus (AGEN) Soars 6.8%: Is Further Upside Left in the Stock?
|
|
Apr 19
|
Regeneron Pharmaceuticals Insiders Sell US$26m Of Stock, Possibly Signalling Caution
|
|
Apr 18
|
Biotech Stock Roundup: REGN, SAGE, NMRA Down on Updates, ITCI Gains on Study Success
|
|
Apr 17
|
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
|
|
Apr 16
|
Why Regeneron (REGN) Could Beat Earnings Estimates Again
|
|
Apr 15
|
UPDATE 1-Regeneron to defend against DOJ complaint on drug-price manipulation
|
|
Apr 15
|
Regeneron to defend against DOJ complaint on drug-price manipulation
|
|
Apr 15
|
Regeneron to defend US Justice Department's complaint on drug-pricing manipulation
|
|
Apr 15
|
Regeneron commits $500M to new venture capital fund
|
|
Apr 14
|
Antitrust fervor is gripping Washington and Silicon Valley. But lawsuits have been declining.
|
|
Apr 12
|
Regeneron (REGN) Accused of Fraudulent Practices Related to Eylea
|
|
Apr 11
|
These Stocks Moved the Most Today: CarMax, Apple, Fastenal, Rivian, Alpine Immune, Nike, Robinhood, Constellation Brands, and More
|
|
Apr 11
|
Stocks to Watch Thursday: Robinhood, Alpine Immune, Constellation Brands
|
|
Apr 11
|
Are Regeneron's Legal Troubles — And Six-Week Slide — A Buying Opportunity?
|
|
Apr 11
|
Dow Jones Lower Despite PPI Inflation Relief; Nvidia, Microsoft Price Targets Raised
|
|
Apr 11
|
US sues Regeneron, alleging false price reporting on Eylea
|
|
Apr 10
|
US Justice department files complaint against Regeneron, alleges fraudulent drug pricing
|
|
Apr 10
|
UPDATE 1-US Justice department files complaint against Regeneron, alleges fraudulent drug pricing
|